Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt. Issue 5 (30th November 2022)
- Record Type:
- Journal Article
- Title:
- Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt. Issue 5 (30th November 2022)
- Main Title:
- Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
- Authors:
- Dahal, Ashata
Shakya, Mila
Pant, Dikshya
Adhikari, Anup
Colin-Jones, Rachel
Theiss-Nyland, Katherine
Pollard, Andrew J.
Basnyat, Buddha
Shrestha, Shrijana - Abstract:
- ABSTRACT: Typhoid is a public health problem in Nepal. To generate evidence on the impact of Typhoid Conjugate Vaccine (TCV), a phase 3, double-blind, randomized controlled trial was conducted in Lalitpur, Nepal. 20, 000 children aged between 9 months and ≤16 years were vaccinated with a new TCV, or control vaccine. Participants were actively followed for safety and efficacy over 2 years through passive surveillance (PS) clinics. Several challenges were encountered during vaccination and PS stemming from misinformation, misconception, and fear around clinical trials in the community. Public engagement (PE) activities were conducted across various tiers moving from decision makers in the first tier; to elected local representatives in the second tier; ending with interaction in community with parents/guardians of the targeted population. Prior and during vaccination, engagement was conducted to inform about the study and discuss the importance of vaccination. Post-vaccination, engagement was conducted to inform about PS clinics, alleviate study concerns and share study updates. Direct and continuous interaction with community stakeholders, including parents/guardians of the targeted population contributed to build trust around the study and community willingness to be involved. It helped to raise awareness, drive away misconceptions, and allowed adaptation according to feedback from community members.
- Is Part Of:
- Human vaccines & immunotherapeutics. Volume 18:Issue 5(2022)
- Journal:
- Human vaccines & immunotherapeutics
- Issue:
- Volume 18:Issue 5(2022)
- Issue Display:
- Volume 18, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 18
- Issue:
- 5
- Issue Sort Value:
- 2022-0018-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-11-30
- Subjects:
- Typhoid -- typhoid conjugate vaccine -- typhoid vaccine acceleration consortium -- public engagement -- school engagement -- children -- community stakeholders -- community-based randomized controlled trial -- community trust
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.tandfonline.com/toc/khvi20/current ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/21645515.2022.2043104 ↗
- Languages:
- English
- ISSNs:
- 2164-5515
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4336.468655
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21819.xml